Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Herlemann

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Der Urologe. Ausg. A|March 19, 2017
[Radical prostatectomy as part of a multimodal concept for patients with prostate cancer and bone metastases at initial diagnosis]A Spek, A Herlemann, C Gratzke, et al.
Der Urologe. Ausg. A|March 19, 2017
[When is surgical treatment indicated in metastatic prostate cancer and what is the scientific rationale?]A Kretschmer, A Herlemann, C G Stief, et al.
Der Urologe. Ausg. A|May 5, 2016
[Focal therapy of prostate cancer in Germany]M Apfelbeck, A Herlemann, C G Stief, et al.
Der Urologe. Ausg. A|February 19, 2013
[Diagnostics of benign prostate syndrome]M Seitz, A Herlemann, G Magistro, et al.
Der Urologe. Ausg. A|February 19, 2013
[Medicinal therapy of benign prostate syndrome with phosphodiesterase-5 inhibitors]A Herlemann, C Gratzke, K-E Andersson, et al.
Der Urologe. Ausg. A|October 7, 2017
[Cytoreductive, radical prostatectomy in metastatic prostate cancer]M Chaloupka, A Herlemann, A Spek, et al.
Aktuelle Urologie|March 24, 2016
[Current Aspects on the Pathogenesis of Urinary Tract Infections]G Magistro, J Marcon, V Beck, et al.
Der Urologe. Ausg. A|March 29, 2017
[Primary prostatic sarcoma - a rare malignancy]A Herlemann, D Horst, M D'Anastasi, et al.
Scandinavian Journal of Urology|December 31, 2020
Postoperative change in Gleason score of prostate cancer in fusion targeted biopsy: a matched pair analysisM Apfelbeck, S Tritschler, D-A Clevert, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Der Urologe. Ausg. A|March 19, 2017
[Radical prostatectomy as part of a multimodal concept for patients with prostate cancer and bone metastases at initial diagnosis]A Spek, A Herlemann, C Gratzke, et al.
Der Urologe. Ausg. A|March 19, 2017
[When is surgical treatment indicated in metastatic prostate cancer and what is the scientific rationale?]A Kretschmer, A Herlemann, C G Stief, et al.
Der Urologe. Ausg. A|May 5, 2016
[Focal therapy of prostate cancer in Germany]M Apfelbeck, A Herlemann, C G Stief, et al.
Der Urologe. Ausg. A|February 19, 2013
[Diagnostics of benign prostate syndrome]M Seitz, A Herlemann, G Magistro, et al.
Der Urologe. Ausg. A|February 19, 2013
[Medicinal therapy of benign prostate syndrome with phosphodiesterase-5 inhibitors]A Herlemann, C Gratzke, K-E Andersson, et al.
Der Urologe. Ausg. A|October 7, 2017
[Cytoreductive, radical prostatectomy in metastatic prostate cancer]M Chaloupka, A Herlemann, A Spek, et al.
Aktuelle Urologie|March 24, 2016
[Current Aspects on the Pathogenesis of Urinary Tract Infections]G Magistro, J Marcon, V Beck, et al.
Der Urologe. Ausg. A|March 29, 2017
[Primary prostatic sarcoma - a rare malignancy]A Herlemann, D Horst, M D'Anastasi, et al.
Scandinavian Journal of Urology|December 31, 2020
Postoperative change in Gleason score of prostate cancer in fusion targeted biopsy: a matched pair analysisM Apfelbeck, S Tritschler, D-A Clevert, et al.
Pageof 1